Abstract
Purpose
This study evaluated the outcomes of radiotherapy (RT) for spinal ependymoma with adverse features, such as incomplete resection or disseminated disease.
Methods
Twenty-five patients underwent RT for spinal cord ependymoma during 1991–2016. Twenty-four patients had gross disease on the pre-RT spinal magnetic resonance images. Six patients (24%) had disseminated disease. The World Health Organization grades were I (12 patients), II (12 patients), and III (1 patient). The RT fields were the tumor bed plus margin in 19 patients (76%), the entire craniospinal axis in 5 patients (20%), and the entire spinal canal with posterior cranial fossa in 1 patient (4%). The median RT dose was 50.4 Gy (range 44.0–59.4 Gy).
Results
The median follow-up was 49 months (range 9–321 months), with 5-year overall and progression-free survival rates of 83.7% and 70.8%, respectively. Relative to patients with grade II/III ependymoma, patients with grade I ependymoma had higher 5-year rates of overall survival (100% vs. 69.4%, P = .088) and progression-free survival (100% vs. 42.3%, P = .02). Disease progression was observed in 4 patients who had grade II ependymoma, including 2 of 6 patients with disseminated disease and 2 of 19 patients with localized disease. Twelve patients (48%) exhibited improved neurological function. One patient who underwent craniospinal irradiation developed late hypopituitarism. No other RT-related late toxicities were observed.
Conclusions
Favorable survival outcomes were achieved using RT for spinal ependymoma with adverse prognostic features. Thus, RT may be an effective treatment option when complete tumor removal cannot be achieved.
Similar content being viewed by others
References
Guomundsson KR (1970) A survey of tumors of the central nervous system in Iceland during the 10-year period 1954–1963. Acta Neurologica Scandinavica 46:538–552
Helseth A, Mork SJ (1989) Primary intraspinal neoplasms in Norway, 1955 to 1986. A population-based survey of 467 patients. J Neurosurg 71:842–845. https://doi.org/10.3171/jns.1989.71.6.0842
Leibowitz U, Yablonski M, Alter M (1971) Tumors of the nervous system: incidence and population selectivity. J Chronic Dis 23:707–721
Schellinger KA, Propp JM, Villano JL, McCarthy BJ (2008) Descriptive epidemiology of primary spinal cord tumors. J Neuro-oncol 87:173–179. https://doi.org/10.1007/s11060-007-9507-z
Poppleton H, Gilbertson RJ (2007) Stem cells of ependymoma. Br J Cancer 96:6–10. https://doi.org/10.1038/sj.bjc.6603519
Bagley CA, Wilson S, Kothbauer KF, Bookland MJ, Epstein F, Jallo GI (2009) Long term outcomes following surgical resection of myxopapillary ependymomas. Neurosurg Rev 32:321–334. https://doi.org/10.1007/s10143-009-0190-8. (Discussion 334)
Brotchi J, Bruneau M, Lefranc F, Baleriaux D (2006) Surgery of intraspinal cord tumors. Clin Neurosurg 53:209–216
Maira G, Amante P, Denaro L, Mangiola A, Colosimo C (2001) Surgical treatment of cervical intramedullary spinal cord tumors. Neurol Res 23:835–842. https://doi.org/10.1179/016164101101199432
Fassett DR, Pingree J, Kestle JR (2005) The high incidence of tumor dissemination in myxopapillary ependymoma in pediatric patients: report of five cases and review of the literature. J Neurosurg 102:59–64. https://doi.org/10.3171/ped.2005.102.1.0059
Gomez DR, Missett BT, Wara WM, Lamborn KR, Prados MD, Chang S, Berger MS, Haas-Kogan DA (2005) High failure rate in spinal ependymomas with long-term follow-up. Neuro-oncology 7:254–259. https://doi.org/10.1215/s1152851704001231
Pica A, Miller R, Villa S, Kadish SP, Anacak Y, Abusaris H, Ozyigit G, Baumert BG, Zaucha R, Haller G, Weber DC (2009) The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network. Int J Radiat Oncol Biol Phys 74:1114–1120. https://doi.org/10.1016/j.ijrobp.2008.09.034
Tsai CJ, Wang Y, Allen PK, Mahajan A, McCutcheon IE, Rao G, Rhines LD, Tatsui CE, Armstrong TS, Maor MH, Chang EL, Brown PD, Li J (2014) Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience. Neurosurgery 75:205–214. https://doi.org/10.1227/neu.0000000000000408. (Discussion 213–204)
Weber DC, Wang Y, Miller R, Villa S, Zaucha R, Pica A, Poortmans P, Anacak Y, Ozygit G, Baumert B, Haller G, Preusser M, Li J (2015) Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network. Neuro-oncology 17:588–595. https://doi.org/10.1093/neuonc/nou293
Akyurek S, Chang EL, Yu TK, Little D, Allen PK, McCutcheon I, Mahajan A, Maor MH, Woo SY (2006) Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center. J Neuro-oncol 80:177–183. https://doi.org/10.1007/s11060-006-9169-2
Volpp PB, Han K, Kagan AR, Tome M (2007) Outcomes in treatment for intradural spinal cord ependymomas. Int J Radiat Oncol Biol Phys 69:1199–1204. https://doi.org/10.1016/j.ijrobp.2007.04.058
Wen BC, Hussey DH, Hitchon PW, Schelper RL, Vigliotti AP, Doornbos JF, VanGilder JC (1991) The role of radiation therapy in the management of ependymomas of the spinal cord. Int J Radiat Oncol Biol Phys 20:781–786
Frankel HL, Hancock DO, Hyslop G, Melzak J, Michaelis LS, Ungar GH, Vernon JD, Walsh JJ (1969) The value of postural reduction in the initial management of closed injuries of the spine with paraplegia and tetraplegia. Paraplegia 7:179–192. https://doi.org/10.1038/sc.1969.30
U.S. Department of Health and Human Services NIoH, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE), Version v4.03. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf
(1995) LENT SOMA tables. Radiother Oncol 35:17–60
Pedziwiatr K, Skowronska-Gardas A, Chojnacka M (2013) Spinal cord ependymoma in children—results of postoperative radiotherapy. Radiother Oncol 106:181–185. https://doi.org/10.1016/j.radonc.2013.02.007
Benesch M, Weber-Mzell D, Gerber NU, von Hoff K, Deinlein F, Krauss J, Warmuth-Metz M, Kortmann RD, Pietsch T, Driever PH, Quehenberger F, Urban C, Rutkowski S (2010) Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database. J Neurosurg Pediatr 6:137–144. https://doi.org/10.3171/2010.5.peds09553
Mccormick PC, Torres R, Post KD, Stein BM (1990) Intramedullary ependymoma of the spinal-cord. J Neurosurg 72:523–532. https://doi.org/10.3171/jns.1990.72.4.0523
Oh MC, Ivan ME, Sun MZ, Kaur G, Safaee M, Kim JM, Sayegh ET, Aranda D, Parsa AT (2013) Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas. Neuro-oncology 15:208–215. https://doi.org/10.1093/neuonc/nos286
Lee SH, Chung CK, Kim CH, Yoon SH, Hyun SJ, Kim KJ, Kim ES, Eoh W, Kim HJ (2013) Long-term outcomes of surgical resection with or without adjuvant radiation therapy for treatment of spinal ependymoma: a retrospective multicenter study by the Korea Spinal Oncology Research Group. Neuro-oncology 15:921–929. https://doi.org/10.1093/neuonc/not038
Halvorsen CM, Kolstad F, Hald J, Johannesen TB, Krossnes BK, Langmoen IA, Lied B, Ronning P, Skaar S, Spetalen S, Helseth E (2010) Long-term outcome after resection of intraspinal ependymomas: report of 86 consecutive cases. Neurosurgery 67:1622–1631. https://doi.org/10.1227/NEU.0b013e3181f96d41. (Discussion 1631)
Rezai AR, Woo HH, Lee M, Cohen H, Zagzag D, Epstein FJ (1996) Disseminated ependymomas of the central nervous system. J Neurosurg 85:618–624. https://doi.org/10.3171/jns.1996.85.4.0618
Kahn J, Loeffler JS, Niemierko A, Chiocca EA, Batchelor T, Chakravarti A (2011) Long-term outcomes of patients with spinal cord gliomas treated by modern conformal radiation techniques. Int J Radiat Oncol Biol Phys 81:232–238. https://doi.org/10.1016/j.ijrobp.2010.05.009
Kim YS, Ahn SD, Choi EK, Kim JH, Lee SW, Noh YJ, Kim CJ, Kim JH, Kwun BD (2002) Ependymoma: a retrospective analysis of 25 cases. Cancer Res Treat 34:450–456. https://doi.org/10.4143/crt.2002.34.6.450
Lin Y, Smith ZA, Wong AP, Melkonian S, Harris DA, Lam S (2015) Predictors of survival in patients with spinal ependymoma. Neurol Res 37:650–655. https://doi.org/10.1179/1743132815y.0000000041
Linstadt DE, Wara WM, Leibel SA, Gutin PH, Wilson CB, Sheline GE (1989) Postoperative radiotherapy of primary spinal cord tumors. Int J Radiat Oncol Biol Phys 16:1397–1403
Oh MC, Tarapore PE, Kim JM, Sun MZ, Safaee M, Kaur G, Aranda DM, Parsa AT (2013) Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci 20:1390–1397. https://doi.org/10.1016/j.jocn.2012.12.010
Sugie C, Shibamoto Y, Ayakawa S, Mimura M, Komai K, Ishii M, Miyamoto A, Oda K (2011) Craniospinal irradiation using helical tomotherapy: evaluation of acute toxicity and dose distribution. Technol Cancer Res Treat 10:187–195. https://doi.org/10.7785/tcrt.2012.500194
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to report.
Ethical approval
The retrospective protocol was approved by our institutional review board (4-2018-0106).
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Byun, H.K., Yi, S., Yoon, H.I. et al. Clinical outcomes of radiotherapy for spinal cord ependymoma with adverse prognostic features: a single-center study. J Neurooncol 140, 649–657 (2018). https://doi.org/10.1007/s11060-018-2995-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-018-2995-1